Related Experiment Video
Updated: Jul 13, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Risk factors for pediatric stroke: consequences for therapy and quality of life
Burkhard Simma1, Gertraud Martin, Thomas Müller
1Department of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch, Feldkirch, Austria. burkhard.simma@lkhf.at
Insights
Pediatric stroke incidence is higher than previously thought, with vasculopathy and lipometabolic disorders being key risk factors. Early therapeutic interventions positively influence long-term outcomes in children with stroke.
Area of Science:
- Neurology
- Pediatrics
- Epidemiology
Background:
- Pediatric stroke is a significant health concern with varying incidence rates.
- Understanding risk factors and long-term outcomes is crucial for optimizing treatment.
Purpose of the Study:
- To determine the incidence of pediatric stroke.
- To identify associated risk factors.
- To evaluate long-term outcomes and inform therapeutic strategies.
Main Methods:
- A retrospective, population-based study of pediatric stroke patients (age >1 month and <19 years) in Vorarlberg, Austria (1984-2005).
- Analysis of neurological deficits, neuropsychological measures, quality of life, and therapeutic interventions.
- Calculation of incidence rates for ischemic and hemorrhagic stroke.
Main Results:
- The incidence was 1.96/100,000 child-years for ischemic stroke and 0.74/100,000 child-years for hemorrhagic stroke.
- Vasculopathy (85%) and lipometabolic disorders (85%) were the most common risk factors.
- Therapeutic consequences were implemented in 65% of cases, including aspirin, folic acid, and rehabilitation.
Conclusions:
- Pediatric stroke often presents with multiple risk factors, primarily vasculopathies and elevated lipoprotein(a).
- Neurological deficits are the primary determinant of outcome.
- A good quality of life positively influences the overall outcome in pediatric stroke survivors.
Abstract:
A retrospective population-based study was conducted to calculate incidence of pediatric stroke, detect risk factors, determine long term outcome and to optimize therapy. Patients (age: >1 month and <19 years) with stroke in Vorarlberg, Austria, from 1984-2005 were investigated. Outcome was evaluated in terms of neurological deficits, neuropsychological measures, and quality of life. Consequences on therapy were established according to current guidelines. Twenty-two children, median age 6 years (range, 0.9-14) years, 16 ischemic and 6 hemorrhagic stroke, correspond to an incidence of 1.96 and 0.74/100.000 child-years, respectively. No child died; one had a recurrent stroke. Twenty children (12 boys) were included after a median time of 3.7 years (range, 0.4-18). Risk factors were vasculopathy (17/20; 85%), lipometabolic disorders (17/20; 85%), and prothrombotic abnormality (10/20; 50%). Three children had no risk factor; four children had a reduced quality of life. The study led to therapeutic consequences in 13 of 20 children (65%): aspirin (5/20; 25%), folic acid in (3/20; 15%), and rehabilitative therapy (9/20; 45%). Most children with pediatric stroke have more than one risk factor, mainly vasculopathies or elevation of lipoprotein(a). Overall outcome is determined solely by neurological deficits and is positively influenced by good quality of life.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
Drug Toxicity: Risk factors
Pharmacokinetics in Pediatric Patients: Drug Metabolism
